Avalon GloboCare director awarded 100,000 stock options
Avalon GloboCare Corp. director Michael Mathews received a grant of 100,000 stock options on June 29, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Avalon GloboCare Corp. director Michael Mathews received a grant of 100,000 stock options on June 29, 2026. The options have an exercise price of $0.2820 per share, are fully vested on the grant date, and are exercisable for Common Stock until June 29, 2029. Following this award, he holds 100,000 derivative securities directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options (right to buy) F1 | 100,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. One hundred percent (100%) of the shares subject to the Option shall vest in full on the grant date.
Key Figures
Key Terms
Options (right to buy) financial
exercise price financial
derivative securities financial
expiration date financial
Grant, award, or other acquisition financial
vest in full on the grant date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Avalon GloboCare (ALBT) director Michael Mathews report on this Form 4?
What is the exercise price of the options granted to the Avalon GloboCare (ALBT) director?
When do Michael Mathews’ Avalon GloboCare (ALBT) options vest?
When do the Avalon GloboCare (ALBT) options granted to Michael Mathews expire?
How many derivative securities does Michael Mathews hold in Avalon GloboCare (ALBT) after this grant?
Is the Form 4 transaction for Avalon GloboCare (ALBT) a market purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.